سوق الأسهم
Grifols prepares stock listing for its US Biopharma business
من إعداد الذكاء الاصطناعي صورة مولدة بواسطة الذكاء الاصطناعي
Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.
The Ibovespa surged 3.24% on Monday (23), reaching 181,900 points, driven by Donald Trump's statements on US-Iran talks. Brent oil dropped 9.6% to $96.3, and the dollar fell to R$5.23.
من إعداد الذكاء الاصطناعي
South Korean shares opened sharply lower on March 19 amid attacks on Middle East energy facilities during the US- and Israel-led war against Iran. The US Federal Reserve's decision to keep rates unchanged further dampened sentiment. The KOSPI fell 2.16% in the first 15 minutes.